"
Team:UT-Tokyo/Project/Inhibition/Background
From 2012.igem.org
| (2 intermediate revisions not shown) | |||
| Line 3: | Line 3: | ||
<html> | <html> | ||
</p><img id="abstimg" src="https://static.igem.org/mediawiki/2012/d/d3/UT-Tokyo_blank01.png" alt="box-background image" /><p> | </p><img id="abstimg" src="https://static.igem.org/mediawiki/2012/d/d3/UT-Tokyo_blank01.png" alt="box-background image" /><p> | ||
| - | <!-- ここから</p>の前までを編集してください --> | + | <!-- ここから</p>の前までを編集してください --> |
| - | + | Here we explain the Background of Inhibition without Knockout project. | |
</p></div><p></html> | </p></div><p></html> | ||
<!-- 以下テンプレ部分まで自由記述 --> | <!-- 以下テンプレ部分まで自由記述 --> | ||
== Background == | == Background == | ||
| - | In project H2 E.coli, we tried to improve the formic acid-hydrogen pathway by overexpressing a gene fhlA which controls a step in this pathway | + | In project H2 E.coli, we tried to improve the formic acid-hydrogen pathway by overexpressing a gene fhlA which controls a step in this pathway. |
| - | However, E.coli possess a protein called HycA in their genome preventing unrestricted hydrogen synthesis. In order to increase the amount of hydrogen | + | However, E.coli possess a protein called HycA coded in their genome preventing unrestricted hydrogen synthesis. In order to increase the amount of hydrogen produced, it was thought that there was a need for systems that inhibit the action of negative factors such as HycA. |
| - | In general, in order to suppress | + | In general, in order to suppress negative factors such as HycA, a gene knockout method is used. However, because it is easier to introduce a plasmid rather than knocking out a gene, we decided to try to suppress these factors by adding Biobrick Parts. A plasmid containing a large number of repeats of the binding site of the factor is introduced into E.coli as a decoy to bind the factors. Thus, the factors bind to the decoy Plasmid and we can reduce the binding to its original binding site to inhibit the function. Additionally, by changing the number of decoy binding sites, transcription can be adjusted stepwise. |
To this end we used LacI and ArgR whose binding sites are known, and introduced multiple copies of their binding sites into plasmids to examine how the expression levels of genes downstream of these proteins were affected. | To this end we used LacI and ArgR whose binding sites are known, and introduced multiple copies of their binding sites into plasmids to examine how the expression levels of genes downstream of these proteins were affected. | ||
| Line 27: | Line 27: | ||
</div><p> | </div><p> | ||
</html> | </html> | ||
| - | {{:Team:UT-Tokyo/Template/Footer|prevname= | + | {{:Team:UT-Tokyo/Template/Footer|prevname=Abstract|prevfull=Project/Inhibition/Abstract|nextname=System|nextfull=Project/Inhibition/System}} |
Latest revision as of 22:56, 26 September 2012
Inhibition without Knockout: Background
Here we explain the Background of Inhibition without Knockout project.
Background
In project H2 E.coli, we tried to improve the formic acid-hydrogen pathway by overexpressing a gene fhlA which controls a step in this pathway.
However, E.coli possess a protein called HycA coded in their genome preventing unrestricted hydrogen synthesis. In order to increase the amount of hydrogen produced, it was thought that there was a need for systems that inhibit the action of negative factors such as HycA.
In general, in order to suppress negative factors such as HycA, a gene knockout method is used. However, because it is easier to introduce a plasmid rather than knocking out a gene, we decided to try to suppress these factors by adding Biobrick Parts. A plasmid containing a large number of repeats of the binding site of the factor is introduced into E.coli as a decoy to bind the factors. Thus, the factors bind to the decoy Plasmid and we can reduce the binding to its original binding site to inhibit the function. Additionally, by changing the number of decoy binding sites, transcription can be adjusted stepwise.
To this end we used LacI and ArgR whose binding sites are known, and introduced multiple copies of their binding sites into plasmids to examine how the expression levels of genes downstream of these proteins were affected.
